A comparative analysis of B7-H3 mRNA levels in the TCGA data set of pancreatic adenocarcinomas, categorized by disease stage (I-IV), showed no significant differences in B7-H3 expression levels (Figure 1B). Here, CD276 is linked to pancreatic adenocarcinoma.